FLUINHIBIT

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFLUINHIBIT
Drug Alias Nameinfluenza polymerase inhibitors (PiKe Pharma)FLUINHIBIT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermanySwitzerland +[4] 
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPiKe Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum fur Infektionsforschung GmbHKlinikum der Albert-Ludwigs Universitaet FreiburgInstitute of Biotechnology IBT +[5] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A